Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 20.20 INR
Change Today +0.05 / 0.25%
Volume 16.3K
MDCB On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 08/5/15 All times are local (Market data is delayed by at least 15 minutes).

medicamen biotech ltd (MDCB) Snapshot

Open
20.20
Previous Close
20.15
Day High
21.45
Day Low
20.00
52 Week High
06/1/15 - 26.35
52 Week Low
03/16/15 - 10.00
Market Cap
189.4M
Average Volume 10 Days
6.1K
EPS TTM
0.49
Shares Outstanding
9.4M
EX-Date
09/21/10
P/E TM
41.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDICAMEN BIOTECH LTD (MDCB)

Related News

No related news articles were found.

medicamen biotech ltd (MDCB) Related Businessweek News

No Related Businessweek News Found

medicamen biotech ltd (MDCB) Details

Medicamen Biotech Limited manufactures and markets pharmaceutical formulations in India and internationally. It offers its products in various forms, such as tablets, capsules, oral liquid, dry syrups, ointment, and ORS. The company was incorporated in 1993 and is based in Delhi, India.

Founded in 1993

medicamen biotech ltd (MDCB) Top Compensated Officers

Founder, Managing Director, Director and Memb...
Total Annual Compensation: 5.0M
Whole Time Director and Member of Stakeholder...
Total Annual Compensation: 2.3M
Whole-Time Director and Member of Quality Ass...
Total Annual Compensation: 503.2K
Compensation as of Fiscal Year 2014.

medicamen biotech ltd (MDCB) Key Developments

Medicamen Biotech Ltd., Board Meeting, Jul 31, 2015

Medicamen Biotech Ltd., Board Meeting, Jul 31, 2015. Agenda: To finalise the notice, venue and date of Annual General Meeting to be held on September 02, 2015.

Medicamen Biotech Ltd Reports Audited Standalone Earnings Results for Fourth Quarter and Year Ended March 31, 2015

Medicamen Biotech Ltd. reported audited standalone earnings results for fourth quarter and year ended March 31, 2015. For the quarter, the company’s net sales/income from operations (net of excise duty) was INR 185.703 million compared to INR 223.917 million a year ago. Profit from operations before other income, finance cost and exceptional items were INR 4.443 million compared to loss of INR 1.110 million a year ago. Loss from ordinary activities before tax was INR 2.326 million compared to INR 4.961 million a year ago. Net profit was INR 0.059 million or INR 0.01 per basic and diluted share before and after extraordinary items compared to loss of INR 4.438 million or INR 0.52 per basic and diluted share before and after extraordinary items for the same period a year ago. For the quarter, the company’s net sales/income from operations (net of excise duty) was INR 777.938 million compared to INR 732.486 million a year ago. Profit from operations before other income, finance cost and exceptional items were INR 18.338 million compared to INR 24.686 million a year ago. Profit from ordinary activities before tax was INR 1.209 million compared to INR 1.787 million a year ago. Net profit was INR 4.406 million or INR 0.49 per basic and diluted share before and after extraordinary items compared to INR 0.942 million or INR 0.11 per basic and diluted share before and after extraordinary items for the same period a year ago.

Medicamen Biotech Ltd. to Report Q4, 2015 Results on May 30, 2015

Medicamen Biotech Ltd. announced that they will report Q4, 2015 results on May 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCB:IN 20.20 INR +0.05

MDCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDCB.
View Industry Companies
 

Industry Analysis

MDCB

Industry Average

Valuation MDCB Industry Range
Price/Earnings 40.0x
Price/Sales 0.1x
Price/Book 0.7x
Price/Cash Flow 7.7x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAMEN BIOTECH LTD, please visit www.medicamen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.